Migraine is associated with poorer workplace productivity and decreased quality of life, and the impact of the condition is greatest in the productive period between 25 and 55 years of age. According to a US review of relevant literature, prophylactic triptan therapy appears to be associated with a significant improvement in worker productivity. The authors of the systematic review suggest that in order to produce relevant and useful findings, further research into the impact of migraine should attempt to identify individuals with undiagnosed migraine and include data on presenteeism (employees coming to work in spite of illness) as well as absenteeism. They also comment that as migraine is an episodic, chronic condition, data should be collected in units of time, preferably with the aid of employee diaries to assist in correct recall.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.